Study to Evaluate the Efficacy and Safety of Exenatide Once-Weekly Injection Compared to Once-Daily Insulin in Type 2 Diabetes Mellitus

NCT00935532 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

427

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: exenatide once weekly
DRUG: insulin glargine

Sponsor

AstraZeneca

Collaborators

[object Object]